Promus Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-401
Closed -$2.85K 325
2025
Q1
$2.85K Hold
401
﹤0.01% 287
2024
Q4
$4.68K Buy
+401
New +$4.68K ﹤0.01% 268